Although elevated CRP concentrations have demonstrated prognostic relevance in prostate cancer, serving as an indicator of cancer-specific survival [35], its limited sensitivity for detecting chronic, localized inflammation in BPH reduces its diagnostic utility in this context. This evidence concerns the gene CRP and benign prostatic hyperplasia.